Zuclopenthixol Tablets Generics - Manufacturers & Suppliers
Clopixol®(EU)
| Product/Composition:- | Zuclopenthixol tablets |
|---|---|
| Strength:- | 10 mg, 25 mg, 40 mg |
| Form:- | Oral Tablets |
| Reference Brands:- | Clopixol®(EU) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Zuclopenthixol tablets are typical antipsychotics that block dopamine D2 receptors in the brain, reducing psychotic symptoms like delusions, hallucinations, and aggression. They are primarily used in the oral management of schizophrenia and other chronic psychotic disorders. The tablets help maintain symptom stability and improve treatment adherence in long-term care.
Zuclopenthixol tablets, used for managing schizophrenia and chronic psychoses, are not FDA-approved in the United States but are authorized in the European Union under the brand Clopixol. EU regulations require GMP compliance, pharmacovigilance systems, and bioequivalence data for registration. U.S. market entry would require a 505(b)(2) or ANDA submission with complete CMC, clinical, and labeling documentation. Regulatory focus includes psychiatric safety profiling and consistent release characteristics. For dossier-ready Zuclopenthixol tablets and to explore other available forms such as IM injections and depot formulations, visit Pharmatradz.com — your trusted platform for global pharmaceutical sourcing.